Pure human gamma-interferon as well as alpha-interferon inhibited induction of immunoglobulin synthesis by Epstein-Barr virus but not by pokeweed mitogen in B lymphocytes from adult but not from newborn humans. The interferons inhibited the infected B lymphocytes directly, irrespective of the Epstein-Barr virus immune status of the donor, and their inhibitory effect was synergistic.
T lymphocytes that suppress the outgrowth of autologous Epstein-Barr virus (EBV)-infected B lymphocytes produce both alpha-interferon (IFN-oa) (1, 25) , and gamma-interferon (IFN--y) (3), suggesting a possible role of IFNs in the regulation of herpesvirus infections. EBV transformation of lymphocytes from adults can be inhibited by exogenous human IFN-a (HuIFN-a) (16, 18, 28) , but not that of umbilical cord blood lymphocytes (20, 28) . Furthermore, passive addition of HuIFN-y suppresses EBV-induced effects in lymphocytes from adults (2, 15) .
Previous investigators have used impure IFN preparations. In this report, we have used highly purified natural HuIFN-y, Escherichia coli-derived recombinant DNA HuIFN--y (rec. HuIFN--y), and highly purified natural HuIFN-a and studied their influence on EBV infection of human mononuclear cells (MNC), making use of the fact that EBV is a direct B-cell activator (5) . As a control, we determined the effect of IFNs on a nonviral activator of human T and B cells (17) , pokeweed mitogen (PWM).
Mononuclear cells (MNC) were separated from the blood of EBV-seropositive and EBV-seronegative healthy adults and from umbilical cord blood samples on a Ficoll-Isopaque gradient (6) . The cells were cultured at 106 MNC per ml of medium in polystyrene test tubes (12 by 75 mm; no. 2058, Falcon Plastics, Oxnard, Calif.). Purified natural HuIFN-a (24), purified natural HuIFN--y (8), or rec. HuIFN-y (11) was added 1 h before the cells were exposed to EBV B95-8 (21) or PWM (17) , and the cells were incubated at 37°C in serum-free RPMI 1640 medium supplemented with antibiotics (100 IU of penicillin and 100 p.g of streptomycin per ml).
The cells were then exposed to EBV or PWM for 1 h, followed by addition of 10% heat-inactivated human AB serum to the cultures. All cultures were incubated at 37°C for 7 days in a humidified atmosphere containing 5% Co2. B lymphocytes were separated by a previously described procedure (29) in which macrophages are removed by carboxyliron treatment and T cells are removed by passing the cells through a nylon-wool column followed by two cycles of E rosetting. This yields a B-cell fraction of 99% purity, as judged by immunoglobulin surface staining. HuIFN Table 1 . These data were the basis for the subsequent calculations of the inhibitory effects of HuIFNs. Pretreating MNC from adults and newborns with HuIFN-a ( Fig. 1) , HuIFN--y, (Fig. 1) , or E. coli-produced rec. HuIFN-y ( Fig. 2) inhibited EBNA expression and polyclonal IgM secretion, whereas no inhibition of IgM secretion was noted in PWM-stimulated MNC except with very high HuIFN-a doses (exceeding 1,000 U/ml). On the contrary, both HuIFN--y and rec. HuIFN--y augmented the PWM-induced IgM response in MNC from adults and also in the two of eight cord blood cultures which responded to PWM by immunoglobulin secretion (data not shown). The inhibitory effect of IFN on EBV-stimulated MNC was dose dependent for all three IFN preparations but could not be demonstrated over a broad dose range in cord blood lymphocytes.
MNC from EBV-seronegative and EBV-seropositive donors were equally sensitive to the effects of exogenous HuIFN--y and HuIFN-a (data not shown). However, it was noted regularly that the number of EBNA-positive cells after 7 days of exposing non-IFN-treated cells to EBV was higher in the MNC from EBV-nonimmune individuals (Table 1) .
Both HuIFN-a and HuIFN--y had a direct effect on the infected B cells, since enriched B-cell cultures (>99% immunoglobulin surface-positive cells) from adult donors were inhibited in induction of IgM synthesis to the same extent as were unseparated MNC from the same donors when pretreated with IFN before EBV exposure (Fig. 3) . This finding was true also for inhibition of EBNA expression and could be demonstrated for both HuIFN--y and HuIFN-a (data not shown).
The effects of adding HuIFN-a and HuIFN--y simultaneously to MNC from adults before EBV exposure were greater than their individual inhibitory effects. These synergistic effects were most pronounced at doses between 1 and 100 U/ml (Fig. 4) .
In principle, the observed effects of IFNs on in vitro EBV infection as well as on immune regulation as a whole have been shown earlier for both HuIFN-a and HuIFN--y (2, 15, 18, 28). However, previous data were generated with impure HuIFN preparations. We therefore undertook a study of these parameters with pure IFNs. We used HuIFN-a that was 100-to 1,000-fold purer than that used in the earlier studies and HuIFN-y that had been purified to homogeneity or prepared by recombinant DNA technology. These purified, or pure, IFNs all affect EBV infection in vitro, whether expressed as development of EBNA or as induction of IgM synthesis, two strictly virus-dependent phenomena. EBNA appears within 24 h of in vitro EBV exposure (9) , and secretion of IgM starts within 5 days post-virus exposure (4). umbilical cord blood were exposed to various doses of highly purified HuIFN--y ( ) or HuIFN-a (....) for 1 h at 37°C. They were then exposed to 0.1 ml of EBV B95-8 supernatant (21) containing 106 infectious units per ml for 1 h. The cultures were then supplemented with heat-inactivated human AB serum (10%) and incubated in 5% CO2 at 37°C. After 1 week the number of PFC was determined by the protein A plaque assay (13 Exogenous HuIFNs inhibited both of these effects, and there was a close correlation between the inhibitory effect, measured as EBNA expression or IgM secretion (Fig. 2 ), for all HuIFNs tested.
These inhibitory effects could not be explained merely by the well-documented nonspecific, antiproliferative influence of IFNs (27) , since PWM-activated MNC from the same blood donors were not at all inhibited (Fig. 2) , nor were EBV-infected lymphocytes from umbilical cord blood (Fig.  1) .
EBNA expression and IgM secretion on day 7 of culture probably result from the additive effect of primary infection and proliferation of infected cells (5) . However, no IgM synthesis could be seen in mitomycin-treated EBV infected cultures (data not shown), whereas EBNA appears only at a low frequency, which is evident as early as day 1 or 2 of culture (14) . Since both EBNA expression and IgM PFC were inhibited by HuIFN-a and HuIFN--y in all experiments, we postulate that the antiviral effects of both of these preparations are due to their effect on primary EBV infection of susceptible B cells, as well as on subsequent virusinduced proliferation, irrespective of the EBV immune status of the donor.
The initial total number of EBNA-positive cells and IgM PFC after 7 days of culture was three times higher in MNC from EBV-seronegative donors than in those from EBVseropositive donors (Table 1 ). This observation indicated to us that under these in vitro conditions, EBNA expression and IgM formation were under some control in the immune individual, perhaps through rapid specific cellular production of HuIFN--y. Indeed, several reports indicate that both HuIFN-y and HuIFN-a can be produced in lymphocytes from immune individuals, whereas only HuIFN-a is synthesized in lymphocytes from nonimmune donors (3, 12, 23, 27) as a result of virus exposure.
Potentiation of the antiviral activities of IFN-1 with IFN--y has been described previously (10) . An indication of such dual importance of HuIFN-a and HuIFN--y was the finding that combinations of the two preparations synergistically inhibited EBV-induced activation of MNC from adults (Fig.   4) . One explanation for the synergistic effects could be that B cells carry separate receptors for HuIFN-a and HuIFN--y (7) .
We believe that the IFN-mediated in vitro effects are brought about by a direct effect on the B lymphocytes, since highly enriched B lymphocyte preparations (>99% immunoglobulin surface-positive cells) were inhibited as effectively as unseparated MNC from the same donors (Fig. 3) .
We 
